NovoCure
NVCR
NVCR
236 hedge funds and large institutions have $1.4B invested in NovoCure in 2024 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 81 increasing their positions, 62 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
236
Holders Change
+18
Holders Change %
+8.26%
% of All Funds
3.42%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
44
Increased
81
Reduced
62
Closed
25
Calls
$29.2M
Puts
$12.6M
Net Calls
+$16.6M
Net Calls Change
+$21.1M
Top Buyers
Top Sellers
1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$31.1M |
2 |
Morgan Stanley
New York
|
$27.5M |
3 |
Capital World Investors
Los Angeles,
California
|
$36.1M |
4 |
Norges Bank
Oslo,
Norway
|
$0 |
5 |
State Street
Boston,
Massachusetts
|
$52.6M |